|
|
|
MIRA INFORM REPORT
|
Report No. : |
493157 |
|
Report Date : |
24.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
DENOVIX, INC. |
|
|
|
|
Registered Office : |
The First
State Registered Agent Company (Registered Agent) 1925 Lovering Ave, Wilmington,
New Castle, DE 19806, USA |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
05.01.2012 |
|
|
|
|
Legal Form : |
Domestic Corporation |
|
|
|
|
Line of Business : |
Subject is a small organization
in the analytical instrument manufacturers industry located in Wilmington,
DE. |
|
|
|
|
No. of Employees : |
14 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
United States |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
UNITED STATES - ECONOMIC OVERVIEW
The US has the most technologically powerful economy in the world, with
a per capita GDP of $57,300. US firms are at or near the forefront in technological
advances, especially in computers, pharmaceuticals, and medical, aerospace, and
military equipment; however, their advantage has narrowed since the end of
World War II. Based on a comparison of GDP measured at purchasing power parity
conversion rates, the US economy in 2014, having stood as the largest in the
world for more than a century, slipped into second place behind China, which
has more than tripled the US growth rate for each year of the past four
decades.
In the US, private individuals and business firms make most of the
decisions, and the federal and state governments buy needed goods and services
predominantly in the private marketplace. US business firms enjoy greater
flexibility than their counterparts in Western Europe and Japan in decisions to
expand capital plant, to lay off surplus workers, and to develop new products.
At the same time, businesses face higher barriers to enter their rivals' home
markets than foreign firms face entering US markets.
Long-term problems for the US include stagnation of wages for
lower-income families, inadequate investment in deteriorating infrastructure,
rapidly rising medical and pension costs of an aging population, energy
shortages, and sizable current account and budget deficits.
The onrush of technology has been a driving factor in the gradual
development of a "two-tier" labor market in which those at the bottom
lack the education and the professional/technical skills of those at the top
and, more and more, fail to get comparable pay raises, health insurance
coverage, and other benefits. But the globalization of trade, and especially
the rise of low-wage producers such as China, has put additional downward
pressure on wages and upward pressure on the return to capital. Since 1975,
practically all the gains in household income have gone to the top 20% of
households. Since 1996, dividends and capital gains have grown faster than
wages or any other category of after-tax income.
Imported oil accounts for nearly 55% of US consumption and oil has a
major impact on the overall health of the economy. Crude oil prices doubled
between 2001 and 2006, the year home prices peaked; higher gasoline prices ate
into consumers' budgets and many individuals fell behind in their mortgage
payments. Oil prices climbed another 50% between 2006 and 2008, and bank
foreclosures more than doubled in the same period. Besides dampening the
housing market, soaring oil prices caused a drop in the value of the dollar and
a deterioration in the US merchandise trade deficit, which peaked at $840
billion in 2008. Because the US economy is energy-intensive, falling oil prices
since 2013 have alleviated many of the problems the earlier increases had
created.
The sub-prime mortgage crisis, falling home prices, investment bank
failures, tight credit, and the global economic downturn pushed the US into a
recession by mid-2008. GDP contracted until the third quarter of 2009, making
this the deepest and longest downturn since the Great Depression. To help
stabilize financial markets, the US Congress established a $700 billion
Troubled Asset Relief Program (TARP) in October 2008. The government used some
of these funds to purchase equity in US banks and industrial corporations, much
of which had been returned to the government by early 2011. In January 2009,
Congress passed and President Barack OBAMA signed a bill providing an
additional $787 billion fiscal stimulus to be used over 10 years - two-thirds
on additional spending and one-third on tax cuts - to create jobs and to help
the economy recover. In 2010 and 2011, the federal budget deficit reached
nearly 9% of GDP. In 2012, the Federal Government reduced the growth of
spending and the deficit shrank to 7.6% of GDP. US revenues from taxes and
other sources are lower, as a percentage of GDP, than those of most other
countries.
Wars in Iraq and Afghanistan required major shifts in national resources
from civilian to military purposes and contributed to the growth of the budget
deficit and public debt. Through 2014, the direct costs of the wars totaled
more than $1.5 trillion, according to US Government figures.
In March 2010, President OBAMA signed into law the Patient Protection
and Affordable Care Act, a health insurance reform that was designed to extend
coverage to an additional 32 million Americans by 2016, through private health
insurance for the general population and Medicaid for the impoverished. Total
spending on healthcare - public plus private - rose from 9.0% of GDP in 1980 to
17.9% in 2010.
In July 2010, the president signed the DODD-FRANK Wall Street Reform and
Consumer Protection Act, a law designed to promote financial stability by
protecting consumers from financial abuses, ending taxpayer bailouts of
financial firms, dealing with troubled banks that are "too big to fail,"
and improving accountability and transparency in the financial system - in
particular, by requiring certain financial derivatives to be traded in markets
that are subject to government regulation and oversight.
In December 2012, the Federal Reserve Board (Fed) announced plans to
purchase $85 billion per month of mortgage-backed and Treasury securities in an
effort to hold down long-term interest rates, and to keep short-term rates near
zero until unemployment dropped below 6.5% or inflation rose above 2.5%. In late
2013, the Fed announced that it would begin scaling back long-term bond
purchases to $75 billion per month in January 2014 and further reduce them as
conditions warranted; the Fed ended the purchases during the summer of 2014. In
2014, the unemployment rate dropped to 6.2%, and continued to fall to 5.5% by
mid-2015, the lowest rate of joblessness since before the global recession
began; inflation stood at 1.7%, and public debt as a share of GDP continued to
decline, following several years of increases. In December 2015, the Fed raised
its target for the benchmark federal funds rate by 0.25%, the first increase
since the recession began. With US GDP growth below 2%, the Fed opted to raise
rates three times since then, and in mid-June 2017, the range for the target
rate stood at 1% to 1.25%.
|
Source
: CIA |
STATUTORY
INFORMATION
|
|
|
Legal
Name: |
DENOVIX, INC. |
|
Trade
Name: |
DENOVIX |
|
ID: |
5091559 |
|
Date
Created: |
2012 |
|
Date
Incorporated: |
1/5/2012 |
|
Legal
Address: |
The First State Registered Agent Company (Registered Agent) 1925 Lovering Ave Wilmington, New Castle DE 19806 USA |
|
Operative
Address: |
3411 Silverside Rd Hanby Building Wilmington, DE 19810 USA USA |
|
Telephone:
|
+1 302 442 6911 |
|
Fax: |
+1 302 792 7400 |
|
Legal
Form: |
Domestic Corporation |
|
Email: |
info@denovix.com |
|
Registered
in: |
DELAWARE |
|
Website:
|
www.denovix.com |
|
Contact: |
Fred Kielhoin, Chief Executive
Officer |
|
Staff: |
14 |
|
Activity: |
NAICS 1: Analytical Laboratory
Instrument Manufacturing SIC 1: Spectroscopic And Other
Optical Properties Measuring Equip. |
|
|
|
BANKS
|
|
|
|
The company does not make its banking data
public |
|
|
|
HISTORY
|
|
|
|
The company was founded in 2012 |
|
|
|
PRINCIPAL
ACTIVITY
|
|
|
Denovix, Inc. is a small organization in the analytical instrument
manufacturers industry located in Wilmington, DE. |
|
|
Products/Services description: |
PRODUCTS: DS-11 FX Spectrophotometer /
Fluorometer DS-11 Spectrophotometer DS-C Cuvette Spectrophotometer QFX Fluorometer FX Fluorometer Module Fluorescence Assays |
|
Brands: |
NA |
|
Sales are: |
Wholesale and Retail |
|
Clients: |
Kimi Srl. Paraguay BIKO PARAGUAY S.A. Paraguay MICROMEDICA S.A.S Colombia |
|
Suppliers: |
NA |
|
Operations area: |
National and International |
|
The company exports to |
Paraguay and Colombia |
|
The subject
employs |
14 employees |
|
Payments:
|
No Complaints |
|
|
|
LOCATION
|
|
|
Headquarters
: |
3411 Silverside Rd Hanby Building Wilmington, DE 19810
USA USA |
|
Comments: |
NA |
|
Branches: |
The company does not have
branches |
|
Main
Competitors |
Bonna-Agela Technologies Inc 2308a Telegraph Rd Wilmington Infrared
Technologies Inc 108 Shinn Cir |
|
Related
Companies: |
Kielvest LLC 3411 Silverside Rd Ste 101hb Wilmington DE 19810-4879 USA |
GROUP
STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders: |
This is a private company. The company does not
disclose information on shareholders. The following information has been
obtained through private sources and could not be confirmed: Major holder is Fred Kielhoin |
|
Management: |
Fred Kielhoin, Chief Executive Officer Teresa Clarke-Myers, Administrator David Ash, Applications Manager Fernando Kielhorn, Managing Director Kevin Kelley, Business Director Deborah Conklin, Technology Manager Dave Ward, Engineering Director |
|
|
|
FINANCIAL
INFORMATION
|
|
|
|
The company does not make its financial statements public. The
following information has been provided by private sources: |
|
|
|
|
USD 2016 |
|
|
Sales |
1,300,000 |
|
Cash
flow |
Normal |
|
|
|
LEGAL
FILINGS
|
|
|
|
|
|
Patents |
APPARATUS AND METHOD FOR MAKING OPTICAL MEASUREMENTS
OF SAMPLES Publication number: 20150233760 Abstract: An improved apparatus and method for
making optical measurements of a sample is described. In one embodiment, the apparatus
is a microvolume sampling mechanism comprised of two opposing optical
measurement surfaces. A sample is held by surface tension between the two
opposing optical measurement surfaces. Light is transmitted through the
sample and received by optical fibers, which measure the absorbance of the
sample. This absorbance can be used to determine the concentration of the
sample. Type: Application Filed: February 14, 2014 Publication date: August 20, 2015 Applicant: DeNovix Inc. Inventors: Fernando F. KIELHORN, David B. Ward Apparatus and method for making optical measurements
of samples Patent number: 9442009 Abstract: An improved apparatus and method for
making optical measurements of a sample is described. In one embodiment, the
apparatus is a microvolume sampling mechanism comprised of two opposing
optical measurement surfaces. A sample is held by surface tension between the
two opposing optical measurement surfaces. Light is transmitted through the
sample and received by optical fibers, which measure the absorbance of the
sample. This absorbance can be used to determine the concentration of the
sample. Type: Grant Filed: February 14, 2014 Date of Patent: September 13, 2016 Assignee: DeNovix, Inc. Inventors: Fernando F. Kielhorn, David B. Ward |
|
|
|
|
Trademarks |
DENOVIX - Trademark Details Status: 700 - Registered Image for trademark with serial number 85669339 Serial Number85669339 Registration Number4292122 Word Mark DENOVIX Status700 - Registered Status Date2013-02-19 Filing Date2012-07-05 Registration Number4292122 Registration Date2013-02-19 Mark Drawing4000 - Standard character mark Typeset Published for Opposition Date2012-12-04 Law Office Assigned Location CodeL30 Employee Name SPARACINO, MARK V DENOVIX - Trademark Details Status: 700 - Registered Image for trademark with serial number 85669384 Serial Number85669384 Registration Number4304632 Word Mark DENOVIX Status700 - Registered Status Date2013-03-19 Filing Date2012-07-05 Registration Number4304632 Registration Date2013-03-19 Mark Drawing5000 - Illustration: Drawing with
word(s)/letter(s)/number(s) in Stylized form Typeset Published for Opposition Date2013-01-01 Law Office Assigned Location CodeL30 Employee Name SPARACINO, MARK V CELL-DOC - Trademark Details Status: 606 - Abandoned - No Statement Of Use Filed Image for trademark with serial number 85745390 Serial Number85745390 Word Mark CELL-DOC Status606 - Abandoned - No Statement Of Use Filed Status Date2013-09-02 Filing Date2012-10-04 Mark Drawing4000 - Standard character mark Typeset Published for Opposition Date2012-12-04 Law Office Assigned Location CodeL30 Employee Name SPARACINO, MARK V EASYAPPS - Trademark Details Status: 700 - Registered Image for trademark with serial number 85876904 Serial Number85876904 Registration Number4570727 Word Mark EASYAPPS Status700 - Registered Status Date2014-07-22 Filing Date2013-03-15 Registration Number4570727 Registration Date2014-07-22 Mark Drawing4000 - Standard character mark Typeset Published for Opposition Date2014-05-06 Law Office Assigned Location CodeM60 Employee Name COLEMAN, NICHOLAS A SMARTPATH - Trademark Details Status: 700 - Registered Image for trademark with serial number 85876911 Serial Number85876911 Registration Number4570728 Word Mark SMARTPATH Status700 - Registered Status Date2014-07-22 Filing Date2013-03-15 Registration Number4570728 Registration Date2014-07-22 Mark Drawing4000 - Standard character mark Typeset Published for Opposition Date2014-05-06 Law Office Assigned Location CodeM60 Employee Name COLEMAN, NICHOLAS A |
|
|
|
|
Cases |
Thermo Fisher Scientific, Inc.
v. Denovix Inc. Plaintiff: Thermo Fisher
Scientific, Inc. Defendant: Denovix Inc. Case Number: 1:2016cv12347 Filed: November 21, 2016 Court: Massachusetts District
Court Office: Boston Office County: Middlesex Presiding Judge: Patti B. Saris Nature of Suit: Patent Cause of Action: 15:1126 Jury Demanded By: Plaintiff |
|
|
|
|
UCC |
No found |
|
|
|
|
OFAC Sanctions List Search |
The company is not listed
in the OFAC list. |
SUMMARY
|
|
|
|
Founded in 2012,
Denovix, Inc. is a small organization in the analytical instrument
manufacturers industry located in Wilmington, DE. The company has 14 full-time
employees and generates an estimated USD 1.3 million in annual revenue. The company exports
to Colombia and Paraguay, operating within national and international
markets. This has been an
ACTIVE company incorporated in DELAWARE in 2012. |
|
|
|
RISK
INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
No Complaints |
|
CASH
FLOW |
Normal |
|
STATUS |
ACTIVE |
|
|
|
|
INTERVIEW |
|
|
NAME |
Teresa |
|
POSITION |
Operator |
|
COMMENTS |
She confirmed legal name, trade
name, address, website, telephone and principal activity. She explained that the company
operates both nationally and internationally. She provided this email for
contact: info@denovix.com She refused to provide neither
staff number nor major holders. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 64.82 |
|
|
1 |
INR 90.40 |
|
Euro |
1 |
INR 79.76 |
|
US Dollar |
1 |
INR 64.71 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
PRA |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.